WASHINGTON (Reuters) – The U.S. Drug Enforcement Administration on Friday reversed an order that halted a Louisiana drug wholesaler’s opioid sales over allegations it failed to report suspiciously large orders by pharmacies for the narcotics, court documents showed.
Source: Reuters Medical News